APOGEN BIOTECHNOLOGIES
 
                    ApoGen Biotechnologies, Inc. is focused on the development of new class of therapeutics targeting drivers of cancer genomic mutation.As the arsenal of available cancer therapies has grown and evolved from cytotoxic chemotherapy to targeted therapy to immunotherapy, one fact has unfortunately remained constant nearly all cancer drug therapies eventually fail due to the development of drug resistance. Mutation of cellular DNA is central to the formation of cancer, and chronic mutation of the cancer genome is a primary cause of cancer evolution and drug resistance, resulting in ineffective therapy, cancer recurrence and metastasis, and decreased overall survival.
APOGEN BIOTECHNOLOGIES
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.apogenbiotech.com
Total Employee:
1+
Status:
Active
Contact:
(206)957-7300
Email Addresses:
[email protected]
Total Funding:
11 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF WordPress Apache Wordpress Plugins Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS
Similar Organizations

Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
Divide and Conquer
Divide & Conquer is a biotechnology company focused on discovery and development of a new class of oncology therapeutics
Current Advisors List

Current Employees Featured


Founder


Investors List
M Ventures
M Ventures investment in Series A - ApoGen Biotechnologies

Alexandria Venture
Alexandria Venture investment in Series A - ApoGen Biotechnologies
ARCH Venture Partners
ARCH Venture Partners investment in Series A - ApoGen Biotechnologies

Johnson & Johnson Innovation
Johnson & Johnson Innovation investment in Series A - ApoGen Biotechnologies

WuXi AppTec
WuXi AppTec investment in Series A - ApoGen Biotechnologies

Watson Fund
Watson Fund investment in Series A - ApoGen Biotechnologies

AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - ApoGen Biotechnologies

Eli Lilly
Eli Lilly investment in Series A - ApoGen Biotechnologies

Accelerator Corp.
Accelerator Corp. investment in Series A - ApoGen Biotechnologies

Washington Research Foundation
Washington Research Foundation investment in Series A - ApoGen Biotechnologies
Official Site Inspections
http://www.apogenbiotech.com
- Host name: 172.67.148.11
- IP address: 172.67.148.11
- Location:  United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

